Comparison of preference for triptans in migraine patients: a randomized,open-label,crossover prospective study
- Conditions
- migraine
- Registration Number
- JPRN-UMIN000003490
- Lead Sponsor
- School of pharmacy, Kitasato university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1)Patients with headache which is inability to distinguish between migraine and nonmigraine 2)Female who are pregnant or may be pregnant 3)Lactation 4)Patients with renal or hepatic impairment 5)Patients with history of myocardial infarction or with symptoms of ischemic heart disease 6)Patients with peripheral vascular disease 7)Patients with history of epileptiform attack or with brain disorder 8)Patients on monoamine oxidase inhibitors or within 2 weeks of discontinuation of monoamine oxidase inhibitors 9)Patients on HIV protease inhibitors 10)Hemodialysis patients 11)Patients on propranolol 12)Uncontrolled hypertension patients 13)Patients with psychiatric disorder which affect participation 14)Patients with hypersensitivity to any component of the study medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method #intensity of headache at 1 hour after taking the medication #intensity of headache at 2 hours after taking the medication #presence or absence of recurrence of migraine from 2 through 24 hours after taking the medication
- Secondary Outcome Measures
Name Time Method #frequency of attacks #consumption of triptans per 8 weeks #consumption of nonsteroidal antiinflammatory drugs(NSAIDs) and other analgestics #HIT-6 scores